Xiting Cao

1.0k total citations
45 papers, 683 citations indexed

About

Xiting Cao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Xiting Cao has authored 45 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 12 papers in Hematology. Recurrent topics in Xiting Cao's work include Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Acute Myeloid Leukemia Research (7 papers). Xiting Cao is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Acute Myeloid Leukemia Research (7 papers). Xiting Cao collaborates with scholars based in United States, China and Japan. Xiting Cao's co-authors include Thomas Burke, Ashwini Arunachalam, David P. Carbone, Amy P. Abernethy, Caroline McKay, Frank Xiaoqing Liu, N. W. Peacock, Anna Gu, Melissa Rammage and James Gilmore and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Xiting Cao

41 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiting Cao United States	14	255	248	174	110	105	45	683
Helen Boyle France	13	157 0.6×	291 1.2×	164 0.9×	110 1.0×	123 1.2×	38	645
Àngels Arcusa Spain	16	616 2.4×	302 1.2×	156 0.9×	234 2.1×	97 0.9×	34	1.0k
V.E.P.P. Lemmens Netherlands	13	498 2.0×	216 0.9×	268 1.5×	55 0.5×	52 0.5×	27	811
Ove Björ Sweden	12	246 1.0×	115 0.5×	138 0.8×	142 1.3×	239 2.3×	19	729
Douglas Adamson United Kingdom	16	276 1.1×	123 0.5×	190 1.1×	179 1.6×	160 1.5×	40	853
Santi Barbera Italy	10	632 2.5×	456 1.8×	113 0.6×	60 0.5×	72 0.7×	17	978
Halla Skúladóttir Denmark	12	309 1.2×	159 0.6×	83 0.5×	45 0.4×	66 0.6×	29	547
Lars‐Erik Rutqvist Sweden	18	788 3.1×	170 0.7×	290 1.7×	194 1.8×	136 1.3×	25	1.2k
J.P. Jacquin France	8	215 0.8×	106 0.4×	79 0.5×	53 0.5×	27 0.3×	12	512
Donald Poon Singapore	10	314 1.2×	103 0.4×	84 0.5×	83 0.8×	90 0.9×	14	774

Countries citing papers authored by Xiting Cao

Since Specialization

Citations

This map shows the geographic impact of Xiting Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiting Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiting Cao more than expected).

Fields of papers citing papers by Xiting Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiting Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiting Cao. The network helps show where Xiting Cao may publish in the future.

Co-authorship network of co-authors of Xiting Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiting Cao. A scholar is included among the top collaborators of Xiting Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiting Cao. Xiting Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cao, Xiting, James M. O’Brien, Elliot K. Fishman, et al.. (2025). Tumor localization strategies of multicancer early detection tests: a quantitative assessment. JNCI Cancer Spectrum. 9(2).

Zhu, Hao, Xinyu Chang, Xiting Cao, et al.. (2024). Cardiovascular death risk in patients with solid tumors: a population-based study in the United States. European Journal of Cancer Prevention. 34(1). 11–23. 1 indexed citations

Lu, Jie, Xiting Cao, Xinyu Chang, et al.. (2023). Associations between physical activity and all-cause and cardiovascular mortality in adults with type 2 diabetes mellitus: A prospective cohort study from NHANES 2007–2018. Primary care diabetes. 18(1). 44–51. 2 indexed citations

Chang, Xinyu, Xiting Cao, Mengying Liu, et al.. (2022). Prognostic characteristics of immune subtypes associated with acute myeloid leukemia and their identification in cell subsets based on single-cell sequencing analysis. Frontiers in Cell and Developmental Biology. 10. 990034–990034. 4 indexed citations

Li, Tianlong, Xiaocan Lei, Xi Chen, et al.. (2022). Mogroside V Improves Follicular Development and Ovulation in Young-Adult PCOS Rats Induced by Letrozole and High-Fat Diet Through Promoting Glycolysis. Frontiers in Endocrinology. 13. 838204–838204. 35 indexed citations

Liu, Mengying, Xinyu Chang, Xiting Cao, et al.. (2022). Comprehensive Analysis of N6-Methyladenosine-Related Long Noncoding RNA Prognosis of Acute Myeloid Leukemia and Immune Cell Infiltration. Frontiers in Genetics. 13. 888173–888173. 9 indexed citations

Mukherjee, Sudipto, Xiting Cao, Rodrigo Maegawa, et al.. (2020). Effectiveness of Second-Line (2L) Tyrosine Kinase Inhibitor (TKI) Therapy after Resistance or Intolerance to a Prior TKI in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase (Ph+ CML-CP). Blood. 136(Supplement 1). 17–18.

Stein, Eytan M., Dominick Latrémouille-Viau, George J Joseph, et al.. (2019). Treatment Patterns and Outcomes in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents: A SEER-Medicare Analysis. Blood. 134(Supplement_1). 3495–3495. 7 indexed citations

Cao, Xiting, Derek Tang, Shoba Ravichandran, et al.. (2019). Real-world Clinical Outcomes of Pazopanib Immediately After Discontinuation of Immunotherapy for Advanced Renal Cell Carcinoma. Clinical Genitourinary Cancer. 18(1). e37–e45. 14 indexed citations

10.

Lee, Dae Ho, Ming‐Sound Tsao, Hiroshi Isobe, et al.. (2018). Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study. PLoS ONE. 13(8). e0202865–e0202865. 55 indexed citations

11.

Lee, Dae Ho, Hiroshi Isobe, Hubert Wirtz, et al.. (2018). Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study. BMC Health Services Research. 18(1). 147–147. 21 indexed citations

12.

Velcheti, Vamsidhar, Pallavi Patwardhan, Frank Xiaoqing Liu, et al.. (2018). Real-world PD-L1 testing and distribution of PD-L1 tumor expression by immunohistochemistry assay type among patients with metastatic non-small cell lung cancer in the United States. PLoS ONE. 13(11). e0206370–e0206370. 52 indexed citations

13.

Arunachalam, Ashwini, Haojie Li, Marisa A. Bittoni, et al.. (2018). Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 19(5). e783–e799. 36 indexed citations

14.

Cao, Xiting, et al.. (2018). Survival Rates and Health Care Costs for Patients With Advanced Bladder Cancer Treated and Untreated With Chemotherapy. Clinical Genitourinary Cancer. 16(4). e909–e917. 14 indexed citations

15.

Kato, Terufumi, Kiyoshi Mori, Koichi Minato, et al.. (2017). P1.06-021 Treatment Patterns and Healthcare Resource Use from a Retrospective Cohort of Japanese Patients with Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(1). S678–S678. 1 indexed citations

16.

Isobe, Hiroshi, Kiyoshi Mori, Koichi Minato, et al.. (2017). Real-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan. PubMed. Volume 8. 191–206. 16 indexed citations

17.

Abernethy, Amy P., Ashwini Arunachalam, Thomas Burke, et al.. (2017). Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting. PLoS ONE. 12(6). e0178420–e0178420. 79 indexed citations

18.

Cao, Xiting, et al.. (2016). Biopsy Procedures and Molecular Testing Utilization and Related Costs in Patients with Metastatic Lung Cancer. Journal of Managed Care & Specialty Pharmacy. 22(10). 1194–1203. 9 indexed citations

19.

McKay, Caroline, Thomas Burke, Xiting Cao, Amy P. Abernethy, & David P. Carbone. (2016). Treatment Patterns for Advanced Non–Small-cell Lung Cancer After Platinum-containing Therapy in U.S. Community Oncology Clinical Practice. Clinical Lung Cancer. 17(5). 449–460.e7. 16 indexed citations

20.

Iglay, Kristy, Xiting Cao, Panagiotis Mavros, et al.. (2015). Systematic Literature Review and Meta-analysis of Medication Adherence With Once-weekly Versus Once-daily Therapy. Clinical Therapeutics. 37(8). 1813–1821.e1. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact